So far, it has only been demonstrated that externally administered PGD2 is able to induce local eosinophilia in different models of inflammation [18-21,51], and that CRTH2 is the cellular mediator for this effect. This evidence concerns the gene PTGDR2 and Increased total eosinophil count.